Advertisement

Topics

Leukocare AG Company Profile

14:27 EST 17th December 2018 | BioPortfolio

LEUKOCARE is a privately held clinical-stage biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany.

LEUKOCARE licenses proprietary technologies for stabilization and protection of proteins and other biologics against chemical and physical stress to partners in the fields of biopharmaceutical, medical device, and diagnostic industries. LEUKOCARE also offers know-how and experience in collaborative product development to support incorporation of the Stabilizing and Protecting Solutions (SPS) into new products.

The benefits of applying LEUKOCARE’s SPS technologies are:

  • Stabilizing biologics (e.g. proteins, vaccines) in pharmaceutical, medical device, and diagnostic applications. Many biological macromolecules are intolerant towards physical or chemical stress. LEUKOCARE’s physiological and sugar free SPS excipient platform extends shelf-life and decreases sensitivity during storage and distribution.
  • Enabling terminal sterilization of biologics by irradiation or EtO. So far, many proteins and other biological macromolecules loose most or even all of their pharmacological activity when irradiated for sterilization purposes by beta or gamma irradiation. LEUKOCARE’s SPS technologies protect biologics against the destructive impact of irradiation. Avoiding aseptic production significantly reduces costs and increases product safety.
  • Functionalizing surfaces (e.g. of medical or diagnostic devices) with biologics. Drug-device combination products are well established in various fields of therapeutic applications. Combining biologics with medical device surfaces, however, is a relatively novel field of research. LEUKOCARE offers research and development services during early planning and design (identifying pathways and effector molecules), prototyping and product development.

LEUKOCARE’s QM system is certified according to EN ISO 9001 and EN ISO 13485.

Location

Am Klopferspitz 19
Martinsried
Munich
Munich
82152
Germany

Contact

Phone: +49 (0)89 780 16 65 – 0
Fax: +49 (0)89 780 16 65 – 11
Email: info@leukocare.com


News Articles [6 Associated News Articles listed on BioPortfolio]

Leukocare partners with Xellia to discover and develop value─added anti─infective therapies

Munich─based biotech company Leukocare AG and Xellia Pharmaceuticals, a specialty pharmaceutical company, announced a global strategic partnership to discover innovative formulations which will

LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies

September 6th 2018: LEUKOCARE AG and Xellia Pharmaceuticals, have entered into a global strategic partnership, where both companies will collaborate closely to discover innovative and superior fo...

Leukocare AG Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryLeukocare AG Leukocare is a clinicalstage biotechnology company that offers technologies for stabilizing proteins to increase shelflife and to facilitate terminal sterilization by irradiation o...

Leukocare AG Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryLeukocare AG Leukocare is a clinicalstage biotechnology company that offers technologies for stabilizing proteins to increase shelflife and to facilitate terminal sterilization by irradiation o...

Leukocare AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryLeukocare AG Leukocare is a clinicalstage biotechnology company that offers technologies for stabilizing proteins to increase shelflife and to facilitate terminal sterilization by irradiation o...

Leukocare AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryLeukocare AG Leukocare is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelflife and to facilitate terminal sterilization by irradiation ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Leukocare AG

LEUKOCARE is a privately held clinical-stage biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany. LEUKOCARE licenses proprietary technologies for stabilization a...

LEUKOCARE AG

LEUKOCARE is a leading provider of technologies for stabilizing proteins to extend shelf-life and to enable terminal sterilization. Based on these technologies, LEUKOCARE can impr...

More Information about "Leukocare AG" on BioPortfolio

We have published hundreds of Leukocare AG news stories on BioPortfolio along with dozens of Leukocare AG Clinical Trials and PubMed Articles about Leukocare AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Leukocare AG Companies in our database. You can also find out about relevant Leukocare AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Stress
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...


Corporate Database Quicklinks



Searches Linking to this Company Record